Economy

Wesbanco Bank Inc. Continues to Hold Stake in Quest Diagnostics Inc (DGX)

Over the past twelve months, Quest Diagnostics Incorporated (NYSE:DGX)'s stock was 1.82%. Voya Investment Management LLC owned about 0.13% of Quest Diagnostics worth $19,879,000 at the end of the most recent quarter. The Company's divisions include Personal & Business Banking (PBB), Commercial & Private Banking (CPB), NatWest Markets (NWM), Capital Resolution, Williams & Glyn (W&G), and Central items & other. The stock of Quest Diagnostics Inc (NYSE:DGX) earned "Buy" rating by UBS on Monday, November 14. The Northcoast Asset Management Llc holds 175,096 shares with $19.46 million value, down from 182,262 last quarter. Clearbridge Ltd stated it has 0% in Quest Diagnostics Inc (NYSE:DGX). Roberts Glore & Company Inc sold 2,720 shares as Quest Diagnostics Inc (DGX)'s stock rose 10.72%. Insiders sold 161,996 shares of company stock valued at $17,517,207 in the last three months. Hills Bank & Trust Co. increased its holdings in shares of Quest Diagnostics by 1.4% in the 2nd quarter. Raymond James Financial, Inc. reissued a market perform rating on shares of Quest Diagnostics in a research report on Monday, September 25th. Ferguson Wellman Capital Management Inc. now owns 4,300 shares of the medical research company's stock valued at $478,000 after acquiring an additional 40 shares during the last quarter. BidaskClub upgraded shares of Quest Diagnostics from a buy rating to a strong-buy rating in a research report on Thursday, June 29th.

With its low price-to-sales ratio of 1.69, the company is evidently a better investment since the investors are paying a lower amount for each unit of sales. Quest Diagnostics has a 52-week low of $79.12 and a 52-week high of $112.97. The firm has a 50 day moving average of $99.64 and a 200-day moving average of $92.34.

Quest Diagnostics Incorporated (DGX) have shown a high EPS growth of 9.70% in the last 5 years and has earnings decline of -7.10% yoy.

The consensus recommendation - averaging the work of 19 analysts - of 2.8 for Quest Diagnostics Incorporated (DGX) points to moderate case.

Roberts Glore & Company Inc decreased Quest Diagnostics Inc (DGX) stake by 15.91% reported in 2017Q2 SEC filing. The firm had revenue of $1.94 billion during the quarter, compared to analyst estimates of $1.94 billion. The 1 year EPS growth rate is 576.00%. The company's revenue was up 1.9% on a year-over-year basis. Equities research analysts predict that Quest Diagnostics will post $5.67 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 18th. The ex-dividend date was Monday, April 3rd. This represents a $1.80 annualized dividend and a yield of 1.92%. Quest Diagnostics's payout ratio is 36.29%. Also, Chairman Stephen H. Rusckowski sold 59,235 shares of the business's stock in a transaction on Tuesday, September 12th. The stock was sold at an average price of $108.16, for a total value of $5,833,393.28. Following the completion of the sale, the chairman now owns 220,049 shares in the company, valued at approximately $23,800,499.84. The big banks are holding 91.70% of the shares while company insiders are clinging to 0.30%. Keybank National Association OH increased its stake in Quest Diagnostics by 2.8% during the first quarter. If you are accessing this news story on another website, it was copied illegally and republished in violation of US & worldwide copyright and trademark laws. The legal version of this piece can be viewed at https://stocknewstimes.com/2017/10/03/quest-diagnostics-incorporated-dgx-lowered-to-hold-at-valuengine.html. Mizuho maintained the shares of DGX in report on Thursday, October 22 with "Neutral" rating. Barclays PLC restated a "hold" rating and set a $110.00 price objective on shares of Quest Diagnostics in a research note on Wednesday, July 19th. Canaccord Genuity maintained Quest Diagnostics Inc (NYSE:DGX) rating on Monday, September 11. Canaccord Genuity reaffirmed a buy rating and issued a $118.00 price target on shares of Quest Diagnostics in a research report on Wednesday, September 13th.

Among 12 analysts covering CalAtlantic Group (NYSE:CAA), 7 have Buy rating, 1 Sell and 4 Hold. Janney Montgomery Scott Ltd Liability reported 0.01% of its portfolio in Quest Diagnostics Inc (NYSE:DGX). The Company operates through two businesses: Diagnostic Information Services and Diagnostic Solutions.



Like this

Latest


03 October 2017
Boy honks after swallowing toy horn
An unfortunate young boy was left honking with every breath after accidentally swallowing a toy party hooter in Argentina. Doctor Santiago Gomez Zuviría posted the video to raise awareness about toy safety and the risks children are exposed to.

03 October 2017
Alleged HTC U11 Life Specs Leaked
Having said that, HTC will first release the HTC U11 Life in the USA , and it may not make into the Indian market anytime soon. The HTC U11 Life being an Android One device is definitely unsurprising as Google has acquired the company's mobile division.

03 October 2017
Stock is up at $39.99 (CDNS) Cadence Genus Synthesis Solution Enables…
Cadence Design Systems Inc . on 6/29/2017 reported its EPS as $0.3 with the analysts projecting the EPS of the stock as $0.28. 02. Facebook, Inc. (NASDAQ:FB) trade at $170.13 by raised 0.39% in most recent trading session with share volume of 1.11 Million.

03 October 2017
The Kraft Heinz's (KHC) Buy Rating Reaffirmed at Royal Bank Of Canada
Always volatility measures make charm for active trader; price volatility of stock was 4.23% for a week and 2.78% for a month. TheStreet upgraded shares of The Kraft Heinz from a "c" rating to a "b-" rating in a research note on Thursday, August 3rd.

03 October 2017
Dynagas LNG Partners LP Common (NYSE:DLNG) Sees Significantly Lower Trading Volume
Dynagas LNG Partners LP is a limited partnership, which focuses on owning and operating liquid natural gas (LNG) carriers. The stock of Dynagas LNG Partners LP (NYSE:DLNG) earned "Market Perform" rating by Wells Fargo on Monday, September 19.

03 October 2017
Chelsea suffer fresh blow as Morata will miss up to six weeks
The striker has been brilliant since he arrived from Real Madrid, but the club will be without their No. 9 for two months now. Mark Ogden chats with Alison Bender outside Stamford Bridge after Manchester City's convincing 1-0 victory over Chelsea .

03 October 2017
IPhone X's TrueDepth camera is years ahead of the Android competition
The technology also helps the Face ID make a complete 3D map of the face, and match it against the stored image on the phone to unlock it.

03 October 2017
Drilling Down Into Bank of America Corporation (BAC)
The stock has "Buy" rating by Deutsche Bank on Wednesday, August 12. ( NASDAQ:HOMB ), 7 have Buy rating, 0 Sell and 4 Hold. It improved, as 56 investors sold CF shares while 125 reduced holdings. 27 funds opened positions while 83 raised stakes.

03 October 2017
Vipshop Holdings Limited (VIPS)- Stocks Trapped in Bearish Claws
Analysts believe that the company has the potential to earn average revenue of $2.29 Billion for the current quarter. The company had revenue of $17.52 billion during the quarter, compared to the consensus estimate of $17.30 billion.

03 October 2017
Father shot in the neck saves dozens in Las Vegas shooting
A GoFundMe page has since gone live to help pay for Smith's medical bills, with the page reaching over $6,400 of its $7,000 goal. In the fundraiser description, she calls Smith "a loving father of 3 children, Jonathan Jr, Jayden Starr and Julian".



Recommended